Patient Follows Through on a Hunch and Gets Expert Help From OHC for Cervical Cancer

OHC, Specialists in Cancer and Blood Disorders

Charlene Crank always took good care of her health. Then, about five years ago, she began having problems related to her thyroid and menopause. While working with her primary care doctor to manage these health issues, she paid less attention to other... Read More

In 2018, OHC was the region’s first adult cancer group to offer chimeric antigen receptor T-cell therapy (CAR-T) to adults with blood cancers. This was a ground-breaking moment in the history of worldwide cancer care and OHC was at the forefront.... Read More

OHC is Giving Hope to Patients With Gallbladder and Bile Duct Cancer

Kurt P. Leuenberger, MD, medical oncologist and hematologist at OHC who specializes in gastrointestinal cancers

February is Gallbladder and Bile Duct Cancer Awareness Month and OHC is giving patients a fighting chance as the only independent cancer group in Ohio to offer a clinical trial for a new treatment for bile duct cancer. The good news about gallbladder... Read More

Every year, Cincinnati magazine issues their Top Docs edition, which lists those doctors voted by other doctors as the top in their field of medicine. OHC once again dominated the three cancer categories. The following OHC doctor are included in the... Read More

OHC Helps You Determine Which Cancer Screenings You Should Have and How Often

OHC, Specialists in Cancer and Blood Disorders

Screenings save lives. They can find diseases early, before you have symptoms, when they’re easier to treat. At OHC, we know that getting the right screening test at the right time is one of the most important things we can do for our health.... Read More

OHC Researchers Continue Their Quest to Find New Treatments for Advanced Breast Cancer

Prasad R. Kudalkar, MD, medical oncologist and hematologist

Cancer researchers at OHC are offering new hope for patients with advanced breast cancer that has not responded to current treatment options or is inoperable. Sometimes the cells in a breast have a gene that has been altered, called a mutation. This... Read More

On Saturday, January 11, OHC’s team of medical, radiation and gynecologic oncology doctors invited all OHC employees to a special celebration to express their gratitude for the exceptional care and compassion they surround patients and their family... Read More

OHC Gynecology Oncologist Reports Decrease in HPV – the Primary Source of Cervical Cancer

OHC, Specialists in Cancer and Blood Disorders

January is Cervical Cancer Awareness Month, and OHC is pleased to share that the primary source of cervical cancer – the HPV virus – has decreased since the introduction of the vaccine, Gardasil. “It’s been almost 15 years since Gardasil was... Read More

OHC Offers Free Head & Neck Cancer Screenings in 2020

OHC, Specialists in Cancer and Blood Disorders

Screenings save lives. It’s been proven time and time again. That’s why OHC will once again offer free head and neck cancers screenings to help people catch potential oral cancers and begin treatment as soon as possible. Close to 53,000 Americans... Read More

A new clinical trial available at OHC is evaluating the use of the immunotherapy drug, durvalumab, for patients with inoperable, early stage non-small cell lung cancer (NSCLC). The survival rate for lung cancer depends on which stage the cancer has... Read More